[go: up one dir, main page]

Follow
Pietro Refolo
Pietro Refolo
Dipartimento di Sicurezza e Bioetica, Università Cattolica del Sacro Cuore
Verified email at unicatt.it
Title
Cited by
Cited by
Year
Guidance on choosing qualitative evidence synthesis methods for use in health technology assessments of complex interventions
A Booth, J Noyes, K Flemming, A Gerhardus, P Wahlster, GJ van der Wilt, ...
Integrated Health Technology Assessment for Evaluating Complex Technologies …, 2016
2962016
Structured methodology review identified seven (RETREAT) criteria for selecting qualitative evidence synthesis approaches
A Booth, J Noyes, K Flemming, A Gerhardus, P Wahlster, GJ van der Wilt, ...
Journal of clinical epidemiology 99, 41-52, 2018
2352018
Health technology assessment (HTA): ethical aspects
D Sacchini, A Virdis, P Refolo, M Pennacchini, I Carrasco de Paula
Medicine, Health Care and Philosophy 12 (4), 453-457, 2009
692009
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use
A Cicchetti, A Berrino, M Casini, P Codella, G Facco, A Fiore, G Marano, ...
Blood transfusion 14 (4), 287, 2016
472016
Ethical analysis in HTA of complex health interventions
KB Lysdahl, W Oortwijn, GJ Van Der Wilt, P Refolo, D Sacchini, ...
BMC Medical Ethics 17 (1), 16, 2016
462016
Integrating ethics in health technology assessment: many ways to Rome
B Hofmann, W Oortwijn, KB Lysdahl, P Refolo, D Sacchini, ...
International journal of technology assessment in health care 31 (3), 131-137, 2015
452015
Lay and professional stakeholder involvement in scoping palliative care issues: methods used in seven European countries
L Brereton, C Ingleton, C Gardiner, E Goyder, K Mozygemba, KB Lysdahl, ...
Palliative medicine 31 (2), 181-192, 2017
432017
Patient-reported outcomes (PROs): the significance of using humanistic measures in clinical trial and clinical practice
P Refolo, R Minacori, V Mele, D Sacchini, AG Spagnolo
Eur Rev Med Pharmacol Sci 16 (10), 1319-1323, 2012
422012
Integrating empirical analysis and normative inquiry in health technology assessment: the values in doing assessments of health technologies approach
GJ Van der Wilt, B Bloemen, J Grin, I Gutierrez-Ibarluzea, ...
International Journal of Technology Assessment in Health Care 38 (1), e52, 2022
352022
Ethics of digital therapeutics (DTx).
P Refolo, D Sacchini, C Raimondi, AG Spagnolo
European Review for Medical & Pharmacological Sciences 26 (18), 2022
342022
Why is it so difficult to integrate ethics in Health Technology Assessment (HTA)? The epistemological viewpoint
P Refolo, D Sacchini, L Brereton, A Gerhardus, B Hofmann, KB Lysdahl, ...
312016
Testing the HTA Core Model: Experiences from two pilot projects
I Pasternack, H Anttila, M Mäkelä, T Ikonen, P Räsänen, K Lampe, ...
International journal of technology assessment in health care 25 (S2), 21-27, 2009
292009
Taking patient heterogeneity and preferences into account in health technology assessments
W Kievit, M Tummers, R Van Hoorn, A Booth, K Mozygemba, P Refolo, ...
International Journal of Technology Assessment in Health Care 33 (5), 562-569, 2017
282017
Stakeholder involvement throughout health technology assessment: an example from palliative care
L Brereton, P Wahlster, K Mozygemba, KB Lysdahl, J Burns, S Polus, ...
International journal of technology assessment in health care 33 (5), 552-561, 2017
282017
The development of PubMed search strategies for patient preferences for treatment outcomes
R Van Hoorn, W Kievit, A Booth, K Mozygemba, KB Lysdahl, P Refolo, ...
BMC medical research methodology 16 (1), 88, 2016
272016
Sobre la «responsabilidad» de la vacunación
ML Di Pietro, P Refolo, FJ González-Melado
Cuadernos de bioetica 23 (2), 323-336, 2012
262012
Ethical and deontological issues in Transfusion Medicine
D Sacchini, GM Liumbruno, G Bruno, C Liumbruno, D Rafanelli, ...
Blood Transfusion 11 (1), 14, 2013
252013
Integrated assessment of home based palliative care with and without reinforced caregiver support:‘a demonstration of INTEGRATE-HTA methodological guidances’–executive summary
L Brereton, P Wahlster, KB Lysdahl, K Mozygemba, J Burns, JB Chilcott, ...
242016
Ethical aspects of fecal microbiota transplantation (FMT)
V Daloiso, R Minacori, P Refolo, D Sacchini, L Craxi, A Gasbarrini, ...
Eur Rev Med Pharmacol Sci 19 (17), 3173-80, 2015
242015
Prioritization of high-cost new drugs for HCV: making sustainability ethical
L Craxi, D Sacchini, P Refolo, R Minacori, V D'Aloiso, G Ricci, R Bruno, ...
European review for medical and pharmacological sciences, 1044-1051, 2016
222016
The system can't perform the operation now. Try again later.
Articles 1–20